Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains.
Pandey, Vikash; Sultan, Marc; Kashofer, Karl; Ralser, Meryem; Amstislavskiy, Vyacheslav; Starmann, Julia; Osprian, Ingrid; Grimm, Christina; Hache, Hendrik; Yaspo, Marie-Laure; Sültmann, Holger; Trauner, Michael; Denk, Helmut; Zatloukal, Kurt; Lehrach, Hans; Wierling, Christoph.
; 9(10): e111006, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25347188
Non-alcoholic fatty liver disease.
Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Effect of diet and omega-3 fatty acids in NAFLD.
Relevance of CYP2E1 to non-alcoholic fatty liver disease.
[Pediatric nonalcoholic fatty liver disease/nonalcoholic steatohepatitis].
Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1.
Spontaneous development of hepatosteatosis in perilipin-1 null mice with adipose tissue dysfunction.
A potential high risk for fatty liver disease was found in mice generated after assisted reproductive techniques.
DLK1/PREF1 regulates nutrient metabolism and protects from steatosis.